Design, Synthesis, Biological Evaluation and Molecular Docking of Novel F-18-Labeled Focal Adhesion Kinase Inhibitors as Potential Tumor Radiotracers

Tumor diagnosis, especially at the early stages, holds immense significance. Focal adhesion kinase (FAK) is often highly expressed across various types of tumors, making it a promising target for both therapy and diagnosis. In this study, seven novel inhibitors were designed and synthesized. The inh...

Full description

Bibliographic Details
Main Authors: Hailong Yang, Ye Li, Huaju Liang, Chun Cui, Lu Gan, Huabei Zhang
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/29/6/1224
_version_ 1827305439821299712
author Hailong Yang
Ye Li
Huaju Liang
Chun Cui
Lu Gan
Huabei Zhang
author_facet Hailong Yang
Ye Li
Huaju Liang
Chun Cui
Lu Gan
Huabei Zhang
author_sort Hailong Yang
collection DOAJ
description Tumor diagnosis, especially at the early stages, holds immense significance. Focal adhesion kinase (FAK) is often highly expressed across various types of tumors, making it a promising target for both therapy and diagnosis. In this study, seven novel inhibitors were designed and synthesized. The inhibitory activity of these compounds against FAK was notably potent, with an IC<sub>50</sub> range of 1.27–1968 nM. In particular, compounds <b>7a</b> and <b>7c</b>, with IC<sub>50</sub> values of 5.59 nM and 1.27 nM, respectively, were radiolabeled with F-18 and then evaluated with S-180 tumor-bearing mice. Subsequently, they exhibited moderate-to-high tumor uptake values, with [<sup>18</sup>F]<b>7a</b> showing 1.39 ± 0.30%ID/g at 60 min post injection and [<sup>18</sup>F]<b>7c</b> demonstrating 6.58 ± 0.46%ID/g at 30 min post injection. In addition, the results from docking studies revealed the binding specifics of the studied compounds. Overall, these findings hold the potential to offer valuable guidance for enhancing the development of radiotracers and enzyme inhibitors.
first_indexed 2024-04-24T17:58:12Z
format Article
id doaj.art-502586b28234485dad6d1f2c1ea9be49
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-04-24T17:58:12Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-502586b28234485dad6d1f2c1ea9be492024-03-27T13:56:47ZengMDPI AGMolecules1420-30492024-03-01296122410.3390/molecules29061224Design, Synthesis, Biological Evaluation and Molecular Docking of Novel F-18-Labeled Focal Adhesion Kinase Inhibitors as Potential Tumor RadiotracersHailong Yang0Ye Li1Huaju Liang2Chun Cui3Lu Gan4Huabei Zhang5Key Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University, No. 19 Xinjiekouwai Street, Haidian District, Beijing 100875, ChinaKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University, No. 19 Xinjiekouwai Street, Haidian District, Beijing 100875, ChinaKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University, No. 19 Xinjiekouwai Street, Haidian District, Beijing 100875, ChinaKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University, No. 19 Xinjiekouwai Street, Haidian District, Beijing 100875, ChinaKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University, No. 19 Xinjiekouwai Street, Haidian District, Beijing 100875, ChinaKey Laboratory of Radiopharmaceuticals of Ministry of Education, College of Chemistry, Beijing Normal University, No. 19 Xinjiekouwai Street, Haidian District, Beijing 100875, ChinaTumor diagnosis, especially at the early stages, holds immense significance. Focal adhesion kinase (FAK) is often highly expressed across various types of tumors, making it a promising target for both therapy and diagnosis. In this study, seven novel inhibitors were designed and synthesized. The inhibitory activity of these compounds against FAK was notably potent, with an IC<sub>50</sub> range of 1.27–1968 nM. In particular, compounds <b>7a</b> and <b>7c</b>, with IC<sub>50</sub> values of 5.59 nM and 1.27 nM, respectively, were radiolabeled with F-18 and then evaluated with S-180 tumor-bearing mice. Subsequently, they exhibited moderate-to-high tumor uptake values, with [<sup>18</sup>F]<b>7a</b> showing 1.39 ± 0.30%ID/g at 60 min post injection and [<sup>18</sup>F]<b>7c</b> demonstrating 6.58 ± 0.46%ID/g at 30 min post injection. In addition, the results from docking studies revealed the binding specifics of the studied compounds. Overall, these findings hold the potential to offer valuable guidance for enhancing the development of radiotracers and enzyme inhibitors.https://www.mdpi.com/1420-3049/29/6/1224FAKinhibitorradiotracerF-18 labelmolecular docking
spellingShingle Hailong Yang
Ye Li
Huaju Liang
Chun Cui
Lu Gan
Huabei Zhang
Design, Synthesis, Biological Evaluation and Molecular Docking of Novel F-18-Labeled Focal Adhesion Kinase Inhibitors as Potential Tumor Radiotracers
Molecules
FAK
inhibitor
radiotracer
F-18 label
molecular docking
title Design, Synthesis, Biological Evaluation and Molecular Docking of Novel F-18-Labeled Focal Adhesion Kinase Inhibitors as Potential Tumor Radiotracers
title_full Design, Synthesis, Biological Evaluation and Molecular Docking of Novel F-18-Labeled Focal Adhesion Kinase Inhibitors as Potential Tumor Radiotracers
title_fullStr Design, Synthesis, Biological Evaluation and Molecular Docking of Novel F-18-Labeled Focal Adhesion Kinase Inhibitors as Potential Tumor Radiotracers
title_full_unstemmed Design, Synthesis, Biological Evaluation and Molecular Docking of Novel F-18-Labeled Focal Adhesion Kinase Inhibitors as Potential Tumor Radiotracers
title_short Design, Synthesis, Biological Evaluation and Molecular Docking of Novel F-18-Labeled Focal Adhesion Kinase Inhibitors as Potential Tumor Radiotracers
title_sort design synthesis biological evaluation and molecular docking of novel f 18 labeled focal adhesion kinase inhibitors as potential tumor radiotracers
topic FAK
inhibitor
radiotracer
F-18 label
molecular docking
url https://www.mdpi.com/1420-3049/29/6/1224
work_keys_str_mv AT hailongyang designsynthesisbiologicalevaluationandmoleculardockingofnovelf18labeledfocaladhesionkinaseinhibitorsaspotentialtumorradiotracers
AT yeli designsynthesisbiologicalevaluationandmoleculardockingofnovelf18labeledfocaladhesionkinaseinhibitorsaspotentialtumorradiotracers
AT huajuliang designsynthesisbiologicalevaluationandmoleculardockingofnovelf18labeledfocaladhesionkinaseinhibitorsaspotentialtumorradiotracers
AT chuncui designsynthesisbiologicalevaluationandmoleculardockingofnovelf18labeledfocaladhesionkinaseinhibitorsaspotentialtumorradiotracers
AT lugan designsynthesisbiologicalevaluationandmoleculardockingofnovelf18labeledfocaladhesionkinaseinhibitorsaspotentialtumorradiotracers
AT huabeizhang designsynthesisbiologicalevaluationandmoleculardockingofnovelf18labeledfocaladhesionkinaseinhibitorsaspotentialtumorradiotracers